数据库共享平台 -- 细胞查询-- 详细信息
       
产品目录号  GKC-LMP010111
产品名称  Human MARK2-A549 KO Cell Pool
基因编号   MARK2
Uniprot_id  Q7KZI7
宿主细胞   A549 
组织来源   人非小细胞肺癌细胞
规格   1×106cells/T25培养瓶或1×106cells/冻存管
培养基  MEM+10%FBS+1%P/S
筛选标记   N/A
生长特性   贴壁细胞,上皮细胞样
培养条件   37℃,5% CO2的培养箱
传代比例   1/2到1/3传代,2-3天长满
筛选标记   N/A
换液频率   2-3天换液
支原体检测结果   阴性
蛋白组验证结果   N/A
抗体验证结果   N/A
目标基因介绍   Serine/threonine-protein kinase (PubMed:23666762). Involved in cell polarity and microtubule dynamics regulation. Phosphorylates CRTC2/TORC2, DCX, HDAC7, KIF13B, MAP2, MAP4 and RAB11FIP2. Phosphorylates the microtubule-associated protein MAPT/TAU (PubMed:23666762). Plays a key role in cell polarity by phosphorylating the microtubule-associated proteins MAP2, MAP4 and MAPT/TAU at KXGS motifs, causing detachment from microtubules, and their disassembly. Regulates epithelial cell polarity by phosphorylating RAB11FIP2. Involved in the regulation of neuronal migration through its dual activities in regulating cellular polarity and microtubule dynamics, possibly by phosphorylating and regulating DCX. Regulates axogenesis by phosphorylating KIF13B, promoting interaction between KIF13B and 14-3-3 and inhibiting microtubule-dependent accumulation of KIF13B. Also required for neurite outgrowth and establishment of neuronal polarity. Regulates localization and activity of some histone deacetylases by mediating phosphorylation of HDAC7, promoting subsequent interaction between HDAC7 and 14-3-3 and export from the nucleus. Also acts as a positive regulator of the Wnt signaling pathway, probably by mediating phosphorylation of dishevelled proteins (DVL1, DVL2 and/or DVL3). Modulates the developmental decision to build a columnar versus a hepatic epithelial cell apparently by promoting a switch from a direct to a transcytotic mode of apical protein delivery. Essential for the asymmetric development of membrane domains of polarized epithelial cells
细胞系生成   采用CRISPR方法生成Human MARK2-A549 KO Cell Pool
数据说明   Sanger 测序结果显示Human MARK2-A549 KO Cell Pool敲除效率为99%
应用   体内和体外测定
复苏   1)在37℃水浴中预热完全培养基。 2)将冻存管在 37℃水浴中解冻1-2分钟。 3)将冻存管转移到生物安全柜中,并用70%乙醇擦拭表面。 4)拧开冻存管管盖,将细胞悬液轻轻转移到含有9mL完全培养基的无菌离心管中。 5)在室温下以125g离心5-7分钟,弃上清。 6)用5mL的完整培养基重悬细胞沉淀,将细胞悬液转移到T25培养瓶中。 7)将细胞转移到37℃,5% CO2的培养箱中培养。 8)参考传代比例:1/2到1/3传代,2-5天长满。
传代   1)待培养瓶中细胞汇合度至80%-90%以上,可进行细胞传代。 2)将培养基、PBS、胰酶(0.25%Trypsin_EDTA Gibco 25200-056)等从4℃冰箱中拿出,置于37℃水浴中温度接近37℃时取出并在瓶子表面喷洒75%酒精后置于生物安全柜中。 3)从培养箱中取出待传代的培养瓶,瓶身喷洒75%酒精后置于生物安全柜中。 4)为避免冲散细胞,沿培养瓶上壁PBS润洗细胞,清洗细胞后弃去,T25加2mL。 5)加入对应体积的胰酶(T75加1.5mL,T25加0.5mL),并轻轻晃动瓶身使胰酶平铺满细胞底部。可根据实际情况适当增加或减少用量。约1-2min后大部分细胞脱落时,加入对应体积的完全培养基终止消化,并用5mL移液管轻轻吹打至细胞全部脱落。 6)将细胞悬液转移至15mL离心管,悬液300g离心5min,弃上清。 7)移取5mL完全培养基重悬细胞,按需求调整接种比例,并补充培养瓶中完全培养基,T75加至13-15mL,T25加至5mL,加1%双抗。 8)盖上瓶盖拧紧后轻轻晃动瓶身,使细胞混合均匀后置于37℃,5% CO4培养箱中。
细胞冻存   1)准备冻存液,并提前预冷。 2)确保待冻存的细胞满足冻存要求,用显微镜检查以下状态:健康的外观及形态特征、所处生长周期(对数晚期)、无污染或衰退迹象。 3)对细胞进行消化及离心处理(具体步骤参考传代培养流程) 4)按照每管1mL的量添加冻存液重悬细胞,吹打均匀后分装至冻存管。 5)将细胞放在程序降温盒中,在-80℃冰箱中冷冻。 6)后续将细胞转移到液氮罐中,以便长期储存。
  返回
0.030107s